Publications


SCHIZOPHRENIA

1. Nopoulos P, Flaum M, Miller D. Atypical neuroleptic malignant syndrome with an atypical neuroleptic. Ann Clin Psychiatry 1990; 2:251-253.

2. Andreasen NC, Nopoulos P, Schultz S, Miller D, Gupta S, Swayze V, Flaum M. Positive and negative symptoms of schizophrenia: past, present, and future. Acta Psychiatr Scand, Supplementum 1994; 90:51-59.

3. Nopoulos P, Flashman L, Flaum M, Arndt S, O'Leary D, Andreasen NC. Stability of cognitive functioning early in the course of schizophrenia. Schizophr Res 1994; 14:29-37.

4. Andreasen NC, Arndt S, Miller D, Flaum M, Nopoulos P. Correlational studies of the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS): an overview and update. Psychopathology 1995; 28:7-17.

5. Andreasen NC, Swayze V, II, O'Leary D, Nopoulos P, Cizadlo T, Harris G, Arndt S, Flaum M. Abnormalities in midline attentional circuitry in schizophrenia: evidence from magnetic resonance and positron emission tomography. Euro Neuropsychopharmacol 1995; 5:37-41.

6. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia: prediction and patterns of change. Arch Gen Psychiatry 1995; 52:352-361.

7. Nopoulos P, Flaum M, Andreasen NC, Swayze VW. Gray matter heterotopias in schizophrenia. Psychiatric Research: Neuroimaging 1995; 61:11-14.

8. Nopoulos P, Torres I, Flaum M, Andreasen NC, Ehrhardt J, Yuh W. Brain morphology in first-episode schizophrenia. Am J Psychiatry 1995; 152:1721-1723.

9. Nopoulos P, Swayze V, Andreasen NC. Pattern of brain morphology in patients with schizophrenia and large cavum septi pellucidi. J Neuropsychiatry Clin Neurosci 1996; 8:147-152.

10. Andreasen N, O'Leary D, Flaum M, Nopoulos P, Watkins G, Ponto LB, Hichwa R. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 1997; 349:1730-1734.

11. Nopoulos P, Flaum M, Andreasen N. Sex differences in brain morphology in schizophrenia. Am J Psychiatry 1997; 154:1648-1654.

12. Nopoulos P, Swayze V, Flaum M, Ehrhardt JC, Yuh WTC, Andreasen NC. Cavum septi pellucidi in normals and patients with schizophrenia as detected by MRI. Biol Psychiatry 1997; 41:1102-1108.

13. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998; 155:1196-1201.

14. Nopoulos P, Flaum M, Arndt S, Andreasen NC. Morphometry in schizophrenia revisited: height and its relationship to premorbid function. Psychol Med 1998; 28:655-663.

15. Nopoulos P, Giedd N, Andreasen NC, Rapoport J. Frequency and severity of enlarged cavum septi pellucidi in childhood-onset schizophrenia. Am J Psychiatry 1998; 155:1074-1079.

16. Nopoulos P, Swayze V, Flaum M, Andreasen NC. Incidence of ectopic gray matter in patients with schizophrenia and healthy controls using magnetic resonance imaging. The J Neuropsychiatry Clin Neurosci 1998; 10:351-353.

17. Tibbo P, Nopoulos P, Arndt S, Andreasen NC. Corpus callosum shape and size in male patients with schizophrenia. Biol Psychiatry 1998; 44:405-412.

18. Andreasen NC, Nopoulos P, O’Leary DS, Miller D, Wassink TH, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry 1999; 46:908-920.

19. Gold S, Arndt S, Nopoulos P, O’Leary D, Andreasen NC. A longitudinal study of cognitive function in first episode and recent onset schizophrenia. Am J Psychiatry 1999; 156:1342-1348.

20. Ho BC, Nopoulos P, Miller D, Andreasen NC. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia. J Clin Psychiatry 1999; 60:658-663.

21. Nopoulos P, Ceilly JW, Gailis EA, Andreasen NC. An MRI study of cerebellar vermis morphology in patients with schizophrenia: evidence in support of the “cognitive dysmetria” concept. Biol Psychiatry 1999; 46:703-711.

22. Wassink T, Andreasen NC, Nopoulos P, Flaum M. Cerebellar morphology as predictor of symptom and psychosocial outcome in schizophrenia. Biol Psychiatry 1999; 45:41-48.

23. Wassink T, Flaum M, Nopoulos P, Andreasen NC. Prevalence of depressive symptoms early in the course of schizophrenia. Am J Psychiatry 1999; 156:315-316.

24. Westmoreland P, Nopoulos P, Andreasen NC, Heckel D, Arndt S. Caudate size in first episode neuroleptic naïve schizophrenic patients measured using an artificial neural network. Biol Psychiatry 1999; 46:712-720.

25. Westmoreland P, Nopoulos P, Miller D, Arndt S, Andreasen NC. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 1999; 156:1200-1204.

26. Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157:808-815.

27. Nopoulos P, Krie A, Andreasen NC. Enlarged cavum septi pellucidi in patients with schizophrenia: clinical and cognitive correlates. J Neuropsychiatry Clin Neurosci 2000; 12:344-349.

28. Fuller R, Nopoulos P, Arndt S, O’Leary D, Ho BC, Andreasen NC. Longitudinal assessment of pre-morbid cognitive functioning in schizophrenia using the Iowa Test of Basic Skills/ Iowa Test of Educational Development. Am J Psychiatry 2001; 159:1183-89.

29. Nopoulos P, Ceilly J, Gailis E, Andreasen NC. An MRI study of midbrain morphology in patients with schizophrenia: relationship to psychosis, neuroleptics, and cerebellar neural circuitry. Biol Psychiatry 2001; 49:13-19.

30. Nopoulos P, Rideout D, Crespo-Facorro B, Andreasen NC. Sex differences in the absence of massa intermedia in patients with schizophrenia versus healthy controls. Schizophr Res 2001; 48:177-185.

31. Andreasen NC, White T, Nopoulos P. Novel methods to study brain morphology in schizophrenia. European Psychiatry: the Journal of the Association of European Psychiatrists 2002; 17:86-87.

32. Chemerinski E, Nopoulos P, Crespo-Facorro B, Andreasen NC, Magnotta V. Morphology of the ventral frontal cortex in schizophrenia: relationship with social dysfunction. Biol Psychiatry 2002; 52:1-8.

33. Kim JJ, Crespo-Facorro B, Andreasen NC, O’Leary DS, Magnotta V, Nopoulos P. Morphology of the lateral superior temporal gyrus in neuroleptic naïve patients with schizophrenia: relationship to symptoms. Schizophr Res 2003; 60:173-181.

34. Milev P, Ho BC, Arndt S, Nopoulos P, Andreasen NC. Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: a prospective longitudinal study with 5-year follow-up. Biol Psychiatry 2003; 54:608-615.

35. Wassink TH, Nopoulos P, Pietila J, Crowe RR, Andreasen NC. NOTCH4 and the frontal lobe in schizophrenia. Am J Med Genet 2003; 118B:1-7.

36. White T, Andreasen NC, Nopoulos P, Magnotta V. Gyrification abnormalities in childhood- and adolescent-onset schizophrenia. Biol Psychiatry 2003; 54:418-426.

37. Crespo-Facorro B, Nopoulos PC, Chemerinski E, Kim JJ, Andreasen NC, Magnotta V. Temporal pole morphology and psychopathology in males with schizophrenia. Psychiatry Res 2004; 132:107-115.

38. Heitmiller D, Andreasen NC, Nopoulos P. Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia is sex dependent. Schizophr Res 2004; 66:137-142.

39. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal MRI study early in the course of schizophrenia. Arch Gen Psychiatry 2004; 60:585-594.

40. Coryell W, Nopoulos P, Drevets W, Wilson T, Andreasen NC. Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. Am J Psychiatry 2005; 162:1706-1712.

41. Ho BC, Andreasen NC, Nopoulos P, Fuller R, Arndt S, Cadoret RJ. Secondary prevention of schizophrenia: Utility of standardized scholastic tests in early identification. Annals of Clinical Psychiatry 2005; 17: 11-18.

42. Kopelman A, Andreasen NC, Nopoulos P. Morphology of the anterior cingulated gyrus in patients with schizophrenia: relationship to typical neuroleptic exposure. Am J Psychiatry 2005;162:1872-1878.

43. McCormick L, Decker L, Nopoulos P, Ho BC, Andreasen N. Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia. Schizophr Res 2005; 80:73.84.

44. Pressler M, Nopoulos P, Ho BC, Andreasen NC. Insular cortex abnormalities in schizophrenia: Relationship to symptoms and typical neuroleptic exposure. Biol Psychiatry 2005; 57:394-398.

45. Spinks R, Nopoulos P, Ward J, Fuller R, Magnotta VA, Andreasen NC. Globus pallidus volume is related to symptom severity in neuroleptic naive patients with schizophrenia. Schizophr Res 2005; 73:229-233.

46. Bigelow N, Paradiso S, Adolphs R, Moser DJ, Arndt S, Heberlein A, Nopoulos P, Andreasen NC. Perception of socially relevant stimuli in schizophrenia. Schizophr Res 2006; 83:257-267.

47. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry. 2010;67(3):255-62. PMCID: 3677042. 

48. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry. 2011;70(7):672-9. PMCID: 3496792.

CLEFT LIP/PALATE

1. Nopoulos P, Berg S, Canady J, Richman L, Van Demark D, Andreasen NC. Abnormal brain morphology in patients with isolated cleft lip and/or palate: a preliminary analysis. Cleft Palate Craniofac J 2000; 37:441-446.

2. Nopoulos P, Berg S, Canady J, Richman L, Van Demark D, Andreasen NC. Increased incidence of a midline brain anomaly in subjects with non-syndromic clefts of the lip and/or palate. J Neuroimaging 2001; 4:418-424.

3. Nopoulos P, Berg S, Canady J, Richman L, Van Demark D, Andreasen NC. Structural brain abnormalities in adult males with clefts of the lip and/or palate. Genet Med 2002; 4:1-9.

4. Nopoulos P, Berg S, Van Demark D, Richman L, Canady J, Andreasen NC. Cognitive dysfunction in adult males with non-syndromic clefts of the lip and/or palate. Neuropsychological 2002; 40:2178-2184.

5. Nopoulos P, Choe I, Berg S, Van Demark D, Canady J, Richman L. Ventral frontal cortex morphology in adult males with isolated orofacial clefts: relationship to abnormalities in social function. Cleft Palate Craniofac J 2005; 42:138-144.

6. Goldsberry G, Hichwa R, O’Leary D, Andreasen NC, Nopoulos P. Functional abnormalities in the neural circuitry of speech and language in adult males with non-syndromic clefts of the lip and/or palate. J Cleft Palate-Craniofac Disord 2006; 43:683-90.

7. Shriver A, Canady J, Richman L, Andreasen NC, Nopoulos P. Structure and function of the superior temporal plane in adult males with cleft lip and palate: pathologic enlargement with no relationship to childhood hearing deficits. J Child Psychology Psychiatry 2006; 47:994-1002.

8. Boes AD, Murko V, Wood JL, Langbehn DR, Canady J, Richman L, Nopoulos P. Social function in boys with cleft lip and palate: relationship to ventral frontal cortex morphology. Behav Brain Res 2007; 181(2): 224-31.

9. Nopoulos P, Canady J, Magnotta V, Langbehn D, Richman L. Abnormal Brain Structure in Children with Isolated Clefts of the Lip and/or Palate. Arch Pediatr Adolesc Med 2007, 161 (8): 753-8.

10. Nopoulos P, Murray J, Schutte B, Richman L. Cognitive dysfunction in adults with Van der Woude syndrome. Genet Med 2007; 9:213-218.

11. Nopoulos P, Richman L, Andreasen NC, Murray JC, Schutte B. Abnormal brain structure in adults with Van der Woude syndrome. Clin Med. 2007; 71:511-517.

12. Conrad A, Richman L, Canady J, Nopoulos P. Increased incidence of neurologic soft signs in children and adolescents with isolated clefts of the lip and/or palate. J Motor Percept. 2008; 106 (1):197-206. PMID: 18459368; NO PMCID REQUIRED.

13. Conrad AL, Richman L, Nopoulos P, Dailey S. Neuropsychological Functioning in Children with Non-Syndromic Cleft of the Lip and/or Palate. Child Neuropsychol. 2009;15(5):471-84. PMCID: 3218568.

14. Weinberg S, Andreasen NC, Nopoulos P. Three-Dimensional Morphometric Analysis of Brain Shape in Nonsyndromic Orofacial Clefting. J Anat. 2009;214(6):926-36. PMCID: 2705301.

15. Conrad A, Dailey S, Richman L, Canady J, Karnell M, Axelson E, Nopoulos P. Cerebellum Structure Differences and Relationship to Speech in Boys and Girls with Nonsyndromic Cleft of the Lip and/or Palate. Cleft Palate Craniofac J. 2010;47(5):469-75. PMCID: 3218570.

16. Nopoulos P, Boes AD, Jabines A, Conrad AL, Canady J, Richman L, Dawson JD. Hyperactivity, impulsivity, and inattention in boys with cleft lip and palate: relationship to ventromedial prefrontal cortex morphology. J Neurodev Disord. 2010;2(4):235-42. PMCID: 3164053.

17. Van der plas E, Conrad A, Canady J, Richman L, Nopoulos P. Effects of unilateral clefts on brain structure. Arch Pediatr Adolesc Med. 2010;164(8):763-8. PMCID: 3612276.

18. Richman LC, McCoy TE, Conrad AL, Nopoulos P. Neuropsychological, Behavioral, and Academic Sequelae of Cleft: Early Developmental, School Age, and Adolescent/Young Adult Outcomes. Cleft Palate Craniofac J. 2011. PMCID: 3408555.

19. van der Plas E, Caspell CJ, Aerts AM, Tsalikian E, Richman LC, Dawson JD, Nopoulos P. Height, BMI, and pituitary volume in individuals with and without isolated cleft lip and/or palate. Pediatr Res. 2012; 71(5):612-8. PMCID: 3637911.

20. DeVolder I, Richman L, Conrad AL, Magnotta V, Nopoulos P. Abnormal cerebellar structure is dependent on phenotype of isolated cleft of the lip and/or palate. Cerebellum. 2013 Apr;12(2):236-44. PMCID: 3566318.

21. Weinberg SM, Parsons TE, Fogel MR, Walter CP, Conrad AL, Nopoulos P. Corpus callosum shape is altered in individuals with nonsyndromic cleft lip and palate. Am J Med Genet A. 2013 161A(5):1002-1007. PMID: 23532928. NO PMCID NEEDED.

22. Chollet MB, Deleon VB, Conrad AL, Nopoulos P. Morphometric analysis of brain shape in children with nonsyndromic cleft lip and/or palate. J Child Neurol 2013; DOI: 10.1177/0883073813510603. PMID: 24381208. NO PMCID NEEDED.

23. DeVolder I, Richman L, Conrad AL, Magnotta V, Nopoulos P. Abnormal cerebellar structure is dependent on phenotype of isolated cleft of the lip and/or palate. Cerebellum. 2013 Apr;12(2):236-44. PMCID: 3566318. 

24. Conrad AL, McCoy TE, DeVolder I, Richman LC, Nopoulos P. Reading in subjects with an oral cleft: Speech, hearing, and neuropsychological skills. Neuropsychol 2014; 28(3):415-422. PMCID: 4076825.

PREMATURITY

1. Nopoulos P, Conrad A, Bell E, Strauss R, Widness J, Magnotta V, Zimmerman B, Georgieff M, Lindgren S, Richman L. Long-term outcome of brain structure in premature infants: effects of liberal versus restricted transfusions. Arch Pediatr Adolesc Med. 2011;165(5):443-50. PMCID: 3622941.

2. Conrad AL, Richman L, Lindgren S, Nopoulos P. Biological and environmental predictors of behavioral sequelae in children born preterm. Pediatrics. 2010;125(1):e83-9. PMCID: 2857764.

3. Erkonen G E, Hermann GM, Miller R L, Thedens D, Nopoulos P, Wemmie J, Roghair RD. Neonatal leptin administration alters regional brain volumes and blocks neonatal growth restriction-induced behavioral and cardiovascular dysfunction in male mice. Pediatr Res 2011; 69(5 Pt 1):406-12. PMCID: 3095021.

4. McCoy TE, Conrad AL, Richman LC, Lindgren SD, Nopoulos PC, Bell EF. Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol. 2011;17(4):347-67. PMCID: 3115491.

5. McCoy TE, Conrad AL, Richman LC, Nopoulos PC, Bell EF. Memory processes in learning disability subtypes of children born preterm. Child Neuropsychol. 2012. PMID: 22375897.

6. Carter CS, Vogel TW, Zhang Q, Seo S, Swiderski RE, Moninger TO, Cassell MD, Thedens DR, Keppler-Noreuil KM, Nopoulos P, Nishimura DY, Searby CC, Bugge K, Sheffield VC. Abnormal development of NG2+PDGFR-α+ neural progenitor cells leads to neonatal hydrocephalus in a ciliopathy mouse model. Nat Med. 2012 Dec;18(12):1797-804. PMCID: 3684048. 

7. McCoy TE, Conrad AL, Richman LC, Brumbaugh JE, Magnotta VA, Bell EF, Nopoulos PC. The relationship between brain structure and cognition in transfused preterm children at school age. Dev Neuropsychol 2014; 39(3):226-232. PMCID: 4071071.

HUNTINGTON’S

1. Beglinger L, Nopoulos P, Jorge R, Langbehn D, Mikos A, Moser D, Duff K, Robinson R, Paulsen J. White matter volume and cognitive dysfunction in early Huntington’s disease. Cog Behav Neurol 2005; 18:102-107.

2. Paulsen J, Nopoulos P, Magnotta V, Mikos A, Paulson H, Andreasen NC. Brain structure in preclinical Huntington’s disease: evidence for abnormal development. Biol Psychiatry 2006; 59:57-63.

3. Nopoulos P, Magnotta V, Paulson H, Mikos A, Andreasen NC, Paulsen J. Morphology of the cerebral cortex in presymptomatic Huntington’s Disease. Am J Psychiatry 2007, 164 (9):1428-34.

4. Duff K, Beglinger L, O’Rourke MD, Nopoulos P, Paulson HP, Paulsen JS. Risperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington’s disease. Ann Clin Psychiatry. 2008; 20:1-3. PMID: 18297579.

5. Magnotta V, Kim J, Koscik T, Beglinger L, Espinso D, Langbehn D, Nopoulos P, Paulsen J. Diffusion Tensor Imaging in Preclinical Huntington’s Disease. Brain Imaging Behav. 2009;3(1):77-84. PMCID: 3057188.

6. Nopoulos P, Aylward E, Ross C, Johnson H, Magnotta V, Juhl A, Pierson R, Mills J, Langbehn D, Paulsen J. Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis. 2010;40(3):544-54. PMCID: 2955824.

7. Paulsen, JS, Nopoulos P, Aylward E, Ross C, Johnson H, Magnotta V, Juhl A, Pierson R, Langbehn D, Nance M. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull. 2010;82(3-4):201-7. PMCID: 2892238.

8. Aylward E, Mills J, Liu D, Nopoulos P, Ross CA, Pierson R, Paulsen JS. Association between Age and Striatal Volume Stratified by CAG Repeat Length in Prodromal Huntington Disease. PLoS Curr. 2011;3:RRN1235. PMCID: 3092625.

9. Aylward, E, Nopoulos P, Ross C, Langbehn D, Pierson R, Mills J, Hohnson H, Magnotta V, Juhl A, Paulsen J. Longitudinal change in regional brain volumes in preclinical Huntington disease. J Neurol Neurosurg Psychiatry. 2011;82(4):405-10. PMCID: 3105627.

10. Nopoulos P, Epping EA, Wassink T, Schlaggar BL, Perlmutter J. Correlation of CAG repeat length between the maternal and paternal allele of the Huntingtin gene: evidence for assortative mating. Behav Brain Funct. 2011;7(1):45. PMCID: 3219594.

11. Nopoulos, P, Aylward E, Ross C, Johnson H, Magnotta V, Juhl A, Pierson R, Mills J, Langbehn D, Paulsen J, Nance M, Barker R. Smaller intracranial volume in prodromal Huntington disease: Evidence for abnormal neurodevelopment. Brain. 2011;134(Pt 1):137-42. PMCID: 3025719.

12. O'Rourke JJ, Adams WH, Duff K, Byars J, Nopoulos P, Paulsen JS, Beglinger LJ. Estimating premorbid functioning in huntington's disease: the relationship between disease progression and the wide range achievement test reading subtest. Arch Clin Neuropsychol. 2011;26(1):59-66. PMCID: 3021970.

13. Aylward EH, Liu D, Nopoulos PC, Ross CA, Pierson RK, Mills JA, Long JD, Paulsen JS, Investigators P-H, Coordinators of the Huntington Study G. Striatal volume contributes to the prediction of onset of Huntington disease in incident cases. Biol Psychiatry. 2012;71(9):822-8. PMCID: 3237730.

14. Byars JA, Beglinger LJ, Moser DJ, Gonzalez-Alegre P, Nopoulos P. Substance abuse may be a risk factor for earlier onset of Huntington disease. J Neurol. 2012. PMCID: 22274789.

15. Lee J, Mathews K, Schlaggar B, Perlmutter J, Paulsen J, Epping E, Burmeister L, Nopoulos P. Measures of Growth in Children at Risk for Huntington Disease. Neurology, 2012. 79(7):668-674. PMCID: 3414667.

16. Beglinger LJ, Prest L, Mills JA, Paulsen JS, Smith MM, Gonzalez-Alegre P, Rowe KC, Nopoulos P, and Uc EY. Clinical predictors of driving status in Huntington disease. Mov Disord. 2012; 27(9):1146-1152. PMCID: 3638899. 

17. Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, Magnotta VA, Paulsen JS, Margolis RL, Albin RL, Miller MI, Ross CA; and the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Hum Brain Mapp. 2012 Dec 20. PMCID: 3715588.

SEX/GENDER DIFFERENCES

1. Nopoulos P, Flaum M, Andreasen N. Sex differences in brain morphology in schizophrenia. Am J Psychiatry 1997; 154:1648-1654.

2. Nopoulos P, Flaum M, O’Leary D, Andreasen NC. Sexual dimorphism in the human brain: evaluation of tissue volume, tissue composition and surface anatomy using magnetic resonance imaging. Psychiatry Res 2000; 98:1-1.

3. Nopoulos P, Rideout D, Crespo-Facorro B, Andreasen NC. Sex differences in the absence of massa intermedia in patients with schizophrenia versus healthy controls. Schizophr Res 2001; 48:177-185.

4. Wood JL, Heitmiller D, Andreasen NC, Nopoulos P. Morphology of the ventral frontal cortex: Relationship to femininity and social cognition. Cereb Cortex 2008; 18(3):534-40. PMID: 17573374. NO PMCID NEEDED. 

5. Wood JL, Murko V, Nopoulos P. Ventral frontal cortex in children: Morphology, social cognition and masculinity/femininity. Soc Cogn Affect Neurosci. 2008; 3(2):168-76. PMCID: 2555466.

6. Koscik T, O’Leary D, Moser D, Andreasen N, Nopoulos P. Sex differences in parietal lobe morphology: Relationship to mental rotation performance. Brain Cogn 2009;69(3):451-9. PMCID: 2680714.

7. Salinas J, Conrad A, Koscik T, Andreasen N, Nopoulos P. Sex differences in parietal lobe structure and development. Gen Med. 2012; 9(1):44-55. PMCID: 3326392. 

8. Belfi AM, Conrad AL, Dawson J, Nopoulos P. Masculinity/femininity predicts brain volumes in normal healthy children. Dev Neuropsychol 2014; 39(1):25-36. PMCID: 4090143.

IMAGING METHODS

1. Magnotta V, Andreasen NC, Harris G, Cizadlo T, Nopoulos P, Schultz S, Flaum M. Quantitative in vivo measurement of gyrification in the human brain. Cereb Cortex 1999; 9:151-160.

2. Ward J, Magnotta V, Andreasen NC, Ooteman W, Nopoulos P, Pierson R. Color enhancement of multispectral magnetic resonance images: improving the visualization of subcortical structures. J Comp Assist Tomogr 2001; 25:942-949. 

3. Spinks R, Magnotta VA, Andreasen NC, Cretsinger K, Ziebell Z, Nopoulos P. Manual and automated measurement of the whole thalamus and mediodorsal nucleus using MRI. Neuroimage 2002; 17:631-642.

4. Cheng P, Magnotta VA, Wu D, Nopoulos P, Moser DJ, Paulsen J, Jorge R, Andreasen NC. Evaluation of the GTRACT diffusion tensor tractography algorithm: A validation and reliability study. NeuroImage 2006; 31:1075-1085.

5. Li W, Andreasen NC, Nopoulos P, Magnotta VA. Automated parcellation of the brain surface generated from magnetic resonance images. Front Neuroinform 2013; 7:23. doi: 10.3389/fninf 2013.

NORMAL AND ABNORMAL BRAIN DEVELOPMENT

1. Nopoulos P, Berg S, Castellenos FX, Delgado A, Andreasen NC, Rapoport JL. Developmental brain anomalies in children with attention deficit hyperactivity disorder. J Child Neurol 2000; 15:102-108.

2. White T, Andreasen NC, Nopoulos P. Brain volumes and surface morphology in monozygotic twins. Cereb Cortex 2002; 12:486-493.

3. Boes A, McCormick LM, Coryell WH, Nopoulos P. Rostral anterior cingulate cortex volume correlates with depressed mood in normal healthy children. Biol Psychiatry. 2008; 63:391-397. PMCID: 2265665.

4. Davis L, Hazlett H, Librant A, Nopoulos P, Sheffield V, Piven J, Wassink T. Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet. 2008; 147B(7):1145-51. PMCID: 2752707.

5. Boes AD, Calarge C, Tranel D, Anderson S, Nopoulos P. Right ventromedial prefrontal cortex volume is a neural correlate of impulse control in normal healthy boys. Soc Cogn Affect Neurosci. 2009; 4(1):1-9. PMCID: 2656876.

6. Van der Plas E, Boes A, Wemmie J, Tranel D, Nopoulos P. Amygdala volume correlates positively with fearfulness in normal healthy girls: Amygdala volume as an endophenotype for internalizing disorders. Soc Cogn Affect Neurosci 2010; 5(4):424-31. PMCID: 2999759.

7. Boes AD, Grafft AH, Charuta J, Chuang NA, Nopoulos P, Anderson SW. Behavioral effects of congenital ventromedial prefrontal cortex malformation. BMC neurology. 2011;11:151. PMCID: 3265436.

8. Boes AD, Mehta S, Rudrauf D, Van der Plas E, Grabowski T, Adolphs R, Nopoulos P. Changes in cortical morphology resulting from long-term amygdala damage. Soc Cogn Affect Neurosci. 2011. PMCID: 3375891.

TRAINING

1. Gallin EK, Le Blanc SM, and Clinical Research Fellowship Program Directors. Launching a New Fellowship for Medical Students: The First Years of the Doris Duke Clinical Research Fellowship Program. J Investig Med 2005; 53:73-81.

AGING

1. Moser DJ, Boles Ponto LL, Miller IN, Schultz SK, Menda Y, Arndt S, Nopoulos PC. Cerebral blood flow and neuropsychological functioning in elderly vascular disease patients. J Clin Exp Neuropsychol. 2012;34(2):220-5. PMCID: 3582376.

2. Rowe Bijanki K, Arndt S, Magnotta V, Nopoulos P, Paradiso S, Matsui JT, Johnson HJ, Moser D. Characterizing white matter health and organization in atherosclerotic vascular disease: A diffusion tensor imaging study. Psychiatry Res 2013; 214(3):389-397. NIHMSID 533721, PMCID IN PROCESS.

SYNDROMES

1. Keppler-Noreuil KM, Blumhorst C, Sapp JC, Brinckman D, Johnston J, Nopoulos PC, Biesecker LG. Brain tissue- and region-specific abnormalities on volumetric MRI scans in 21 patients with Bardet-Biedl syndrome (BBS). BMC Med Genet. 2011;12:101. PMCID: 3199749.

2. Lee JC, Nopoulos PC, Tomblin JB. Abnormal subcortical components of the corticostriatal system in young adults with DLI: A combined structural MRI and DTI study. Neuropsycholog 2013; 51(11):2154-2161. PMCID: 3816105.